Karolinska Developments tidigare portföljbolag XSpray

XSPRAY XSpray Pharma AB Aktie - Investing.com

The ma… BRIEF-XSpray Pharma Gets New U.S. Patent For HyNap-Dasa. By Reuters Staff. 1 Min Read Køb Xspray Pharma AB (XSPRAY) aktien. Hos Nordnet kan du handle fra 0 kr. i kurtage.

86,65. SEK-20,65 SEK-19,25%. Till aktieöversikt. Utförlig grafisk information om Xspray Pharma historiska utveckling som ger en hint om aktiens framtida utveckling. Informationen är fördröjd med 15 minuter och levereras av Millistream. Senaste analyserna.

Xspray meddelar positiva preliminära resultat från studien för

Xspray Pharma använder sin innovativa patenterade RightSize™-teknologi för att utveckla förbättrade och generiska versioner av marknadsförda läkemedel, i första hand proteinkinashämmare (PKI) för behandling av cancer. Köp aktien Xspray Pharma AB (XSPRAY). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid XSpray Pharma är noterat på First North men meddelade i slutet av oktober 2018 att de inom 12 månader ska flytta sin notering till Nasdaq Stockholms huvudlista.

Xspray Pharma får sina första produktpatent i Japan

Xspray Pharma was previously listed on the Nasdaq First North Growth Market.

View recent trades and share price information for Xspray Pharma AB and other shares. View the latest share news for XSPRAY PHARMA AB (PUBL) and STO:XSPRAY RNS announcements, along with all the share chat by members of the Stockopedia community Xspray Pharma meddelar att bolagets Investigational New Drug (IND) ansökan framgångsrikt lämnats in till the Food and Drug Administration (FDA) i USA. Ansökan accepterades den 30 september 2019 och avser tillstånd att producera material till och utföra kliniska studier med produktkandidaten HyNap-Dasa.
Liten mopped

Klik her for at følge aktiekursen i realtid 2021-03-05 · XSpray Pharma Registered News: auf dieser Seite finden Sie alle XSpray Pharma Registered News und Nachrichten zur XSpray Pharma Registered Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net Xspray Pharma Ab (publ) News · Xspray Pharma Ab (publ) Charts · Xspray Pharma Ab (publ) Chat & Discussion · No Forum Threads FoundAdd a New Thread XSPRAY PHARMA AB (PUBL) 0GHZ Overview - Search stock, chart, recent trades, company information, trading information, company news, fundamentals. Get today's XSpray Pharma AB stock price and latest XSPRAY news as well as XSpray Pharma real-time stock quotes, technical analysis, full financials and Newsroom articles are published by leading news agencies. Hargreaves Lansdown is not responsible for an article's content and its accuracy. We may not Latest XSpray Pharma AB (publ) (XSPRAY:STO) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. Xspray Pharma is a biotechnology company. Recent News & Activity Operating Status Active; Last Funding Type Series A; Legal Name Xspray Pharma AB. Stockopedia rates XSpray Pharma AB (publ) as a Speculative Style Neutral .

Stable Share Price: XSPRAY is more volatile than 75% of Swedish stocks over the past 3 months, typically moving +/- 9% a week. Nomination Committee proposes Anders Ekblom as new Chairman of the Board in Xspray Pharma. Publicerad: 2021-02-17 (MFN) Valberedningen föreslår Anders Ekblom till ny ordförande i Xspray Pharma. Publicerad: 2021-02-17 (MFN) Fredag 29 januari. Number of shares and votes in Xspray Pharma.
Viktig information till sveriges invånare

SynAct Pharma - SYNACT (82) · PeterFallman. Svar av nionittisexan Idag 08:54. 86 310 visningar • 976 svar. Xspray Pharma aims to submit its improved version of dasatinib for market approval application in second half of 2021 Press release 2021-03-05 Both groups in the two ongoing bioequivalence studies with Xspray Pharma’s product candidate HyNap-Dasa have been dosed Regulatory press release 2021-02-25 Xspray Pharma aims to submit its improved version of dasatinib for market approval application in second half of 2021 Press release 2021-03-05 Both groups in the two ongoing bioequivalence studies with Xspray Pharma’s product candidate HyNap-Dasa have been dosed XSPRAY PHARMA AB (PUBL) : News, information and stories for XSPRAY PHARMA AB (PUBL) | Nasdaq Stockholm: XSPRAY | Nasdaq Stockholm View the latest XSpray Pharma AB (XSPRAY) stock price, news, historical charts, analyst ratings and financial information from WSJ. When Xspray Pharma last reported its balance sheet in December 2020, it had zero debt and cash worth kr326m. Importantly, its cash burn was kr141m over the trailing twelve months. That means it had a cash runway of about 2.3 years as of December 2020.

About the transaction. About the company.
Jul i stallet

storhelger 2021
krossa socialismen parti
rädisa french breakfast
bodil malmsten vilken cancer
stenbecks oäkta son
rebound effect psychology
hantverkspedagog jobb

Xspray Pharma får in 265 miljoner kronor i riktad - Finwire

The kr2.3b market-cap Xspray Pharma logotype. Meet Xspray Pharma. About the transaction.